Therapeutic management of chronic venous insufficiency: Microcirculation as a target

Microcirculation

Volumn 7, Issue SUPPL.1, 2000, Pages

  Bergan, John J ^a,b,c   Schmid Schönbein, Geert W ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

microcirculation; venous insufficiency; Venous valves

Indexed keywords

ARTICLE; BLOOD; CELL ADHESION; CHRONIC DISEASE; DRUG EFFECT; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LEUKOCYTE; METABOLISM; MICROCIRCULATION; PATHOLOGY; PATHOPHYSIOLOGY; SKIN; VASCULAR ENDOTHELIUM; VEIN; VEIN INSUFFICIENCY;

CELL ADHESION; CHRONIC DISEASE; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LEUKOCYTES; MICROCIRCULATION; SKIN; VEINS; VENOUS INSUFFICIENCY;

EID: 0034566739     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1080/mic.7.S1.S23.S28     Document Type: Article

References (46)

1. Abu-Own A, Sarin S. (1998). Compression treatment in venous disease. In: Microcirculation in Venous Disease, Second Edition (Coleridge-Smith, PD, Ed.) Landes Bioscience. Austin, TX.
2. Angle N, Bergan JJ. (1997). Chronic venous ulcer. Br Med J 314:1019-1023.
3. Bao X, Lu C, Frangos JA. (1999). Temporal gradient in shear but not steady shear stress induces PDFG-A and MCP-1 expression in endothelial cells: Role of NO, NF kappa B and erg-1. Arterioscler Thromb Vasc Biol 19:996-1003.
4. 99m red cells. Application to the pharmacodynamic activity of Daflon 500 mg. Int Angiol 7(suppl 2):35-38.
5. Bergan JJ. (1999). Application of microcirculatory principles in the treatment of chronic venous insufficiency. Microcirculation 23:194-206.
6. Bergan JJ. (1999). Commentary. Patients with combined deep venous incompetence and venous ulceration do not benefit from perforating vein surgery. Vasc Surg Outlook 10,11:1-2.
7. Bergan JJ, Ballard JL. (1997). Pathophysiology of chronic venous insufficiency. In: Atlas of Endoscopic Perforator Vein Surgery. (Bergan JJ, Gloviczki P, Eds.) Springer-Verlag. London. pp. 45-58.
8. Braide M, Blixt A, Bagge U. (1986). Leukocyte effects on the vascular resistance and glomerular filtration of the isolated rat kidney at normal and low flow rates. Circ Shock 20:71-80.
9. Callam MJ, Ruckley CV, Harper DR, Dale JJ. (1985). Chronic ulceration of the leg: Extent of the problem and provision of care. Br Med J 290:1855-1856.
10. Coleridge Smith PD. (1999). Neutrophil activation and mediators of inflammation in chronic venous insufficiency. J Vasc Res 36:24-36.
11. Coleridge Smith PD, Thomas P, Scurr JH, Dormandy JA. (1988). Causes of venous ulceration: A new hypothesis. Br Med J 296:1726-1727.
12. Colgan M-P, Dormandy JA, Jones PW, Schraibman IG, Shanik DG. (1990). Oxpentifylline treatment of venous ulcers of the leg. Br Med J 300:972-975.
13. Cotton LT. (1961). Varicose veins: Gross anatomy and development. Br J Surg 48:589-598.
14. Dale JJ, Ruckley CV, Harper DR, Gibson B, Nelson EA, Prescott RJ. (1995). A randomized double-blind placebo-controlled trial of oxpentifylline in the treatment of venous leg ulcers. Phlebology 10(suppl 1): 917-918.
15. Davies P. (1995). Flow-mediated endothelial mechanotransduction. Physiol Rev 75:519-560.
16. Fukuda S, Yasu T, Schmid-Schönbein GW. (2000). The regulation of leukocyte response to shear stress by nitric oxide and cGMP. Circ Res 86:E13-E18.
17. Galley P, Thiollet M (1993). A double-blind, placebo-controlled trial of a new venoactive flavonoid fraction (S 5682) in the treatment of symptomatic capillary fragility. Int Angiol 12,1:69-72.
18. Guilhou JJ, Dereure O, Marzin L, Ouvry P, Zuccarelli F, Dubure C, Van Landuyt H, Gillet-Terver MN, Guillot B, Levesque H, Mignot J, Pillion G, Février B, Dubeaux D. (1997). Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients. Angiology 48:77-85.
19. Gliński W, Chodynicka B, Rozkiewicz J, Bogdanowski T, Lecewicz-ToruńB, Kaszuba A, Bowszyc J, Nowak A, Wnorowski J, Wasik F, Glińska-Ferenz M, Blaszczyk M, Strzyga P, Pachocki R. (1999). The beneficial augmentative effect of micronised purified flavonoid fraction (MPFF) on the healing of leg ulcers: an open multicentre, controlled randomised study. Phlebology 14:151-157
20. Hahn J, Jünger M, Friedrich B, Zuder D, Steins A, Hahn M, Klyscz T. (1997). Cutaneous inflammation limited to the region of the ulcer in chronic venous insufficiency. VASA 26:277-281.
21. Hahn TL, Unthank JL, Lalka SG. (1999). Increased hindlimb leukocyte concentration in a chronic rodent model of venous hypertension. J Surg Res 81:38-41.
22. Hauer G, Bergan JJ, Werner A, Mitterhusen M, Nasralla F. (1999). Development of endoscopic dissection of perforating veins and fasciotomy for treatment of chronic venous insufficiency. Ann Vasc Surg 13:357-364.
23. Homans J. (1917). The etiology and treatment of varicose ulcer of the leg. Surg Gynecol Obstet 24: 300-311.
24. Hoshino S, Satakawa H, Iwaya F, Igari T, Ono T, Takase S. (1993). External valvuloplasty under preoperative angioscopic control. Phlébologie 46:521-529.
25. Jünger M, Hahn M, Klyscz T, Steins A. (1999). Role of microangiopathy in the development of venous leg ulcers. Prog Appl Microcirc 23:180-193.
26. Linas DL, Shanley PF, Whittenburg D, Berger E, Repine JE. (1988). Neutrophils accentuate ischemiareperfusion injury in isolated perfused rat kidneys. Am J Physiol 255:F728-F735.
27. Michiels C, Arnould T, Knott I, Dieu M, Remacle J. (1993). Stimulation of prostaglandin synthesis by human endothelial cells exposed to hypoxia. Am J Physiol 264:C866-C874.
28. Moazzam F, DeLano FA, Zweifach BW, Schmid- Schönbein GW. (1997). The leukocyte response to fluid stress. Proc Nat Acad Sci USA 94:5338-5343.
29. Moyses C, Cederholm-Williams SA, Michel CC. (1987). Hemoconcentration and the accumulation of white cells in the feet during venous stasis. Int J Microcirc Clin Exp 5:311-320.
30. Ono T, Bergan JJ, Schmid-Schönbein GW, Takase S. (1998). Monocyte infiltration into venous valves. J Vasc Surg 27:158-166.
31. Partsch H. (1984). Das offene Bein. Klinische Pathophysiologie Ther Umsch 41:825-833.
32. Peschen M, Lahaye T, Hennig B, Weyl A, Simon JC, Vanscheidt W. (1999). Expression of the adhesion molecules ICAM-1, VCAM-1, LFA-1, and VLA-4 in the skin is modulated by progressing stages of chronic venous insufficiency. Acta Derm Venereol (Stockh) 79:27-32.
33. Rudovsky G. (1989). Intravenous prostaglandin E1 in the treatment of venous ulcers: A double-blind, placebo- controlled trial. VASA (suppl 28):39-43.
34. Sales CM, Rosenthal D, Petrillo KA, Jerivs HS, Matsuura J, Clark MD, Pontoriero MA, Syracuse DC, Luka NL. (1998). The valvular apparatus in venous insufficiency: a problem of quantity? Ann Vas Surg 12:153-155.
35. Schmeller W, Roszinski S, Tronnier M, Gmelin E. (1992). Combined morphological and physiological examinations in lipodermatosclerosis. In: Phlebologie 92. (Raymond-Martimbeau P, Prescott R, Zummo M, Eds.) John Libbey Eurotext. Paris. pp. 172-174.
36. Shoab SS, Porter J, Scurr JH, Coleridge-Smith PD (2000). Effect of oral micronized purified flavonoid fraction treatment on leukocyte adhesion molecule expression in patients with chronic disease: a pilot study. J Vasc Surg 31:456-461.
37. Sullivan GW, Carper HT, Novick WJ, Mandell GL. (1988). Inhibition of the inflammatory reaction of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function of pentoxifylline. Infect Immun 56:1722-1729.
38. Takase S, Lerond L, Bergan JJ, Schmid-Schönbein GW. (2000). The inflammatory reaction during venous hypertension in the rat. Microcirculation 7:41-52.
39. Takase S, Schmid-Schönbein G, Bergan JJ. (1999). Leukocyte activation in patients with venous insufficiency. J Vasc Surg 30:148-156.
40. Thomas PRS, Nash GB, Dormandy JA. (1988). White cell accumulation in the dependent legs of patients with venous hypertension: A possible mechanism for trophic changes in the skin. Br Med J 296:1693-1695.
41. Topper JN, Cai J, Falb D, Gimbrone MA Jr. (1996). Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: Cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively upregulated by steady laminar shear stress. Proc Nat Acad Sci USA 93:10417-10422.
42. van Bemmelen SP, Hoynck van Papendrecht AA, Hodde KC, Klopper PJ. (1986). A study of valve incompetence that developed in an experimental model of venous hypertension. Arch Surg 121:1048-1052.
43. Van Cleef JF, Hugentobler JP, Desvaux P, Griton P, Cloarec M. (1992). [Endoscopic study of reflux of the saphenous valve]. J Mal Vasc 17(supp B):113-116.
44. Wilson JW. (1972). Leukocyte sequestration and morphologic augmentation in the pulmonary network following hemorrhagic shock and related forms of stress. Adv Microcirc 4:197-232.
45. Yamada T, Tomita S, Mori M, Sasatomi E, Suenaga E, Itoh T. (1996). Increased mast cell infiltration in varicose veins of the lower limbs: A possible role in the development of varices. Surgery 119:494-497.
46. Yamakawa T, Suguyama I, Niimi H. (1984). Behavior of white blood cells in microcirculation of the cat brain cortex during hemorrhagic shock: Intravital microscopic study. Int J Microcirc Clin Exp 3:554.